GTHP · Guided Therapeutics, Inc.

Summary

On March 2, 2026, Guided Therapeutics, Inc. completed a Warrant Exchange of certain Eligible Warrants from its September 1, 2022 Private Offering, issuing 4,825,000 shares of restricted Common Stock and receiving $980,000 in cash proceeds. This increased outstanding Common Stock from 86,691,976 to 91,516,976 shares, with 16,398,080 Eligible Warrants remaining outstanding.

Key takeaways

• Warrant Exchange completed on March 2, 2026, for Eligible Warrants at 1 share of Common Stock per warrant.
• 4,825,000 Eligible Warrant Shares tendered, representing 22.7% of outstanding Eligible Warrants.
• Company issued 4,825,000 shares of restricted Common Stock on March 2, 2026.
• Received $980,000 cash proceeds from warrant exercises.
• Common Stock outstanding increased to 91,516,976 shares as of March 2, 2026.
• 16,398,080 Eligible Warrants remain, with 11,973,080 expiring September 1–October 18, 2026 and 4,425,000 expiring September 1–October 18, 2027.